Clinical Trials · NCT01237197
Exenatide in Extreme Pediatric Obesity
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Minnesota
- Enrollment
- 26
- Start date
- Oct 2010
- Locations
- 2 sites, United States
- Primary endpoint
- Percent Change From Baseline in Body Mass Index at 3-months